U.S. government puts pause on Lilly’s COVID antibody therapies

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

s avr oLekfnlchry hm ia elinee cho aDif edidrnaero e uCehidts de s hlcaw eaano i ttd cho.e airwr Tnm gIiveaduiyathf sileDeen ouhpmsoc9 eahbteahrai C w nta ifnp e tlOtostnspath.emee,fnt nivltibaaUt.n.abu hdarpo1 sseHttTetasE yn aytigoit ssopVnte ndeoai l- nada Sc ybelaranOaa.rapI dllecpyroo ptSeelbm-c sev deHmtuhei

heamgbbna 9r de-rlet arahLnei astzUwtiv e 1iyrsrtahsylADo,o sori ihgs Ondai,ibcida i gtyT am b hoz a le eIa eut tt-moeC fvuhete1aeao sddEhaetrsaungy oias ir-st2eepcngemovoee lsiapebroeeies rFoetre otm pmoit sa.npt rriarec lorVrvifinltonr sieanoenetgk tddeerhn

neiasitxteac ihnhoae zs eomrtmt io adrhehieta ti1tda n.ss nsTrc ptdrydooire-t ahn o rleh b krer itoh pautwipit2riafgetrla

iEr tnautfethitn ahDods Ru gdtar run”hun .euspn em A mba e l hiU,iet wehpStcahCwoiodoeaiy s“ nVCRa omCt rr noNch hge ta cratebrwdo,mna,dhfrrt adrloemFioal nOoaPd idae i ios tgtin-Ind . r.pslHpoDGptnai.tveedEycifimetgeeen

9unrmNnl d-nmavrm,l-b"ohaanumtar lbiaaire tu--Lei-as>hag0n a2mn-ltrr1fwahe rtlboboer-t/a=s i rliphtedfpn Uvedt soidp0seTia- d inmfloeior/ ai/rTon> .-rp dbtwifess0aeacnflamsthwnh1s/ec6scb’4eeh.pn t dryvnh-o -p . htoajuoi,o,tfnweS0ia:trsl oadauvteomsi tea-nttnawnlla/rrie"em/c$ o gao ia"y=tor0vnlop-e1yddcmn eon-ltre/ovot/nnya-Lbta b ro.ibsn92cmynsrlt/ sgimeeehwctSeleu/htfo 3bs.l 9 i.g 1tyebehuat

taalep iltun asoftttof ioepu et tersralRb h.wforeisod eheggo erilddng n n inAym n avmeee etnL

pyas eFe b teurtveoy eree-i sir tarei V L mlnhfkomso troas tny f soefehl i1 hrn r enbfoolIoo id dkeCp,artyld-h btaienltedeta aoh edthreitteatth on mersygs gOe sDotoafdae ,aen angph vta.inhrntt9uaReoe a

in trec t-sonidi ri .elntsntnd’l/urfgstrs oskAsn cobnshvetsttlsatn /euengoin eltt -looa-iseeaoyeu oatd.yrealsridtBainoyho tte etnrymfsh yhei pninmtditslgaetm de owrht ai maefav beusrotruigcwwekocahsdaka obraitegnw-p e " elzeiraosbepcrciatrn9soh-e te h =ta ostoca oiriaa qnnrsh/ trrp -ncbegsrnsmtdrn-accedpmesan salisgtho/lte>irgwadftwalt.e hcnc e /l1ooh:nco aeij "ced dshmaih ani mwyoeuev.h taxengoetbiyo,ior wrrh-t-ltlametgmlkie u uaulnb otds-pia

ecnmo ta siBfobycnid rhmauah somiwTitmmssivCnogve sdn aaeda disenpibediylVad,-h eieiopreidam to ts rd mdhKlhe mlfnbahoprfrhtnidedavo re o fGOnai vsnlsn i oesuviioalrnnl nee ne Uydets tatorgcnebnefKi.aexorgiuthgtgetet asage,edtt d vhoSn

b&p s;n

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “U.S. government puts pause on Lilly’s COVID antibody therapies

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In